Login / Signup

A phase II clinical trial of lenalidomide intensification in patients with serologic/asymptomatic progression of multiple myeloma while on lenalidomide maintenance: a tri-state transplant consortium study.

Hani HassounRuthee BayerSean DevlinTheresa GentileMichael BeckerKristen O'DweyerMartin LesserHeather J LandauDavid ChungSergio Giralt
Published in: Leukemia & lymphoma (2020)
Keyphrases
  • multiple myeloma
  • phase ii
  • clinical trial
  • open label
  • newly diagnosed
  • double blind
  • phase iii
  • stem cell transplantation
  • study protocol
  • placebo controlled
  • randomized controlled trial
  • coronavirus disease